Abstract:Objective: Perimembranous ventricular septal defects (PMVSDs) is the most common type of congenital ventricular septal defects (VSD), which accounts for 70% approximately 80% of VSD. The structure of PMVSDs is very complex, it is close to tricuspid valve, mitral valve and aortic valve. The atrioventricular (AV) node is located in the posterior upper membranous ventricular septum and branches into left and right bundle in the posterior lower margin. This increases the risk of transcatheter closure of PMVSDs. Arrhythmias is the common complication after transcatheter closure of PMVSDs. The present study aimed to identify the risk factors resulting in arrhythmias after transcatheter closure of PMVSDs in patients under 18 years of age to decrease the incidence of arrhythmias after the interventional catheterization. Methods: A retrospective analysis was performed on the patients treated with transcatheter intervention from June 2002 to June 2004. Transcatheter closure of PMVSDs with Amplatzer membranous septal occluder and a domestic product was performed in 89 cases after obtaining consent themselves and/or their guardian or parents, 47 cases were males and 42 females. The age of the cases ranged from 3 to 18 years (mean 8.2 years) and the body weight ranged from 13 to 55 kg (mean 26.7 kg). They were all diagnosed as having PMVSDs with trans-thoracic echocardiography (TTE) before the interventional catheterization, the electrocardiographic (ECG) and chest X-ray (CXR) findings were recorded. A simultaneous care ECG and TTE were performed during operation in order to identify the effect of the transcatheter closure, the heart structure and functional changes and whether or not arrhythmias occurred, respectively. In 80 cases AGA Amplatzer membranous septal occluder was used and in 9 cases a domestic product was used. Follow-up was performed based on the echocardiography and ECG. Results: The devices were successfully implanted in 89 cases; 11 cases (12%) developed various block of heart conduction within 5 days, which included first degree AV block in 1 patient, third degree AV block in 1, left anterior bundle branch block in 5, partial right bundle branch block in 4, complete right bundle branch block in 3, and 3 patients had two kinds of heart block. Eight patients were treated with corticosteroids, 6 of them recovered within 14 days, 1 patient within 1 month and in 1 case the problem shifted from first degree block and left anterior bundle branch block to left anterior bundle branch block 5 days later and that persisted for 6 months. It was found that the distance from upper margin of defects to the aortic valve < 3 mm, the diameter of ventricular septal defect > or = 8 mm, the diameter of device > or = 10 mm, blood pH < 7.35 and arteriovenous track building time after the success of the Seldinger technique > or = 60 min were independent predictors of post-closure arrhythmias. Conclusion: Arrhythmias remain the severe early complications after interventional catheterization for PMVSDs in patients under 18 years of age. Shortening of operation time, prevention of acidosis and strict selection of indications may be the most effective measures to prevent arrhythmias after transcatheter closure of PMVSDs in patients under 18 years of age.

[Cardiac arrhythmias in adults with congenital heart disease]

Tachyarrhythmias in congenital heart disease

Arrhythmias in Adult Congenital Heart Disease Heart Failure

Arrhythmias in Congenital Heart Disease: a Nationwide Cohort Study

Arrhythmia burden in patients with congenital heart disease

Diagnosis and Treatment of Arrhythmias in Children with Congenital Heart Disease after Surgery

Contemporary Clinical Management of Atrial Septal Defects in the Adult

Atrial Septal Defects in the Adult: Management, Transcatheter and Surgical Therapeutic Options and Outcomes

Study Progress of Diagnosis and Management of Arrhythmias Associated with Congenital Heart Disease in Children

Adults with Congenital Heart Disease (ACHD)

Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts

Procedural factors associated with early postoperative arrhythmias after repair of congenital heart defects

Cardiac Arrhythmias and Their Management: An In-Depth Review of Current Practices and Emerging Therapies

Prevalence of and risk factors for perioperative arrhythmias in neonates and children after cardiopulmonary bypass: continuous holter monitoring before and for three days after surgery

[Risk factors for arrhythmia early after transcatheter closure of perimembranous ventricular septal defects]

Treatment of Fetal Arrhythmias

Pathophysiology and treatment of adults with arrhythmias in the emergency department, part 1: Atrial arrhythmias

Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association

Challenges in the Diagnosis of Adult Congenital Heart Diseases

Inherited conditions of arrhythmia: translating disease mechanisms to patient management

Neonatal cardiac arrhythmia: a retrospective analysis of 128 cases